non-Hodgkin's lymphoma

Non-Hodgkin’s lymphoma trials increase in the 5 years since 2019
Clinical Trials Arena
Thu, 07/25/24 - 09:43 pm
non-Hodgkin's lymphoma
clinical trials
The hangover: Caribou's allogeneic CAR-T hit by durability doubts as half of patients relapse
Fierce Biotech
Fri, 06/10/22 - 10:55 am
Caribou Biosciences
CRISPR
CAR-T
allogenic CAR-T
EHA
non-Hodgkin's lymphoma
FDA approves first biosimilar for NHL
BioCentury
Thu, 11/29/18 - 12:00 am
Celltrion
Teva Pharmaceutical
non-Hodgkin's lymphoma
Truxima
biosimilars
rituximab
Jumping ahead of AstraZeneca, AbbVie and J&J get a green light to market Imbruvica/Rituxan combo for rare lymphoma
Endpoints
Mon, 08/27/18 - 10:02 am
AbbVie
JNJ
FDA
Imbruvica
Rituxan
Roche
AstraZeneca
non-Hodgkin's lymphoma
Waldenström’s macroglobulinemia
Genmab hits roadblock in non-Hodgkin lymphoma
Biopharma Dive
Sat, 05/26/18 - 09:20 am
Genmab
non-Hodgkin's lymphoma
Arzerra
clinical trials
Phase 2 data for Roche’s lymphoma ADC doesn’t disappoint
Fierce Biotech
Tue, 12/12/17 - 10:10 am
Roche
ASH17
clinical trials
non-Hodgkin's lymphoma
antibody-drug conjugate
Move over, Novartis: Kite and Gilead break into CAR-T market with early axi-cel nod
Fierce Pharma
Thu, 10/19/17 - 09:12 am
Gilead Sciences
Kite Pharma
Novartis
CAR-T
FDA
axi-cel
Yescarta
non-Hodgkin's lymphoma
large B-cell lymphoma
ASCO17: Juno marks progress with second-gen CAR-T
BioPharma Dive
Tue, 06/6/17 - 12:16 pm
ASCO 2017
Juno Therapeutics
CAR-T
JCAR017
non-Hodgkin's lymphoma
JCAR015
Bayer cancer drug boards path to speedy approval at FDA
Fierce Biotech
Wed, 05/17/17 - 09:41 am
Bayer
FDA
copanlisib
priority review
non-Hodgkin's lymphoma
AbbVie Is Focused on Label Expansion of Imbruvica in 2017
Market Realist
Tue, 05/2/17 - 11:22 am
AbbVie
Imbruvica
non-Hodgkin's lymphoma
mantle cell lymphoma
graft vs host disease
Looking for Darzalex sales expansion, J&J, Genmab hit a wall in lymphoma
Fierce Pharma
Tue, 04/4/17 - 07:29 pm
Darzalex
JNJ
Genmab
non-Hodgkin's lymphoma
Kite Pharma hits its Q1 deadline on filing a BLA for its pioneering CAR-T, posts improved data
Endpoints
Fri, 03/31/17 - 10:06 pm
Kite Pharma
CAR-T
KTE-C19
non-Hodgkin's lymphoma
Kite Hits 52-Week High on Positive Study
Investopedia
Wed, 03/1/17 - 11:30 am
Kite Pharma
KTE-C19
non-Hodgkin's lymphoma
Kite Pharma Details KTE-C19 Launch Preparedness and Near-Term, Next Generation CAR/TCR Product Candidates at Investor Day
Yahoo
Thu, 10/20/16 - 09:17 am
Kite Pharma
KTE-C19
CAR-T
non-Hodgkin's lymphoma
Epizyme’s Cancer Drug Studies to Continue; Some Tumors Wiped Out
Bloomberg
Mon, 06/20/16 - 09:53 am
Epizyme
cancer
tazemetostat
non-Hodgkin's lymphoma
Infinity Pharma to lay off one-fifth of staff in wake of phase 2 setback
BioPharma Dive
Wed, 06/15/16 - 05:41 pm
Infinity Pharma
layoffs
clinical trials
duvelisib
non-Hodgkin's lymphoma
Epizyme lays out plans to have its cancer drug approved as soon as 2018
Bizjournals.com
Thu, 03/10/16 - 10:51 am
Epizyme
tazemetostat
solid tumors
non-Hodgkin's lymphoma
Novartis: Lymphoma study shows CART on track for 2017 U.S. submission
Yahoo/Reuters
Sun, 12/6/15 - 11:06 am
Novartis
CAR-T
CTL019
non-Hodgkin's lymphoma
Immune Design and Merck to Collaborate on Combination Trials of Two Immune Design Immunotherapies With Merck's KEYTRUDA for Non-Hodgkin's Lymphoma and Melanoma
Yahoo
Mon, 08/10/15 - 08:08 am
Keytruda
Immune Design
Merck
clinical trials
melanoma
non-Hodgkin's lymphoma
LV305
G100
Novartis, Juno Killer T-Cells Show Promise In Another Blood Cancer
Forbes
Tue, 06/2/15 - 09:05 am
Novartis
Juno Therapeutics
CAR-T
non-Hodgkin's lymphoma

Pages